(Total Views: 168)
Posted On: 01/17/2023 12:30:03 PM
Post# of 104161
$BIEL Wearable, noninvasive, pulsed shortwave (radiofrequency) therapy for analgesia and opioid sparing following outpatient surgery: A proof-of-concept case series
https://pubmed.ncbi.nlm.nih.gov/36463434/
Quote:
Case report: Following moderately painful ambulatory umbilical (n = 3) and inguinal (n = 2) hernia repair as well as bilateral breast surgery (n = 2), patients had taped over their surgical incision(s) 1 or 2 noninvasive, wearable, disposable, pulsed shortwave therapy devices (RecoveryRx, BioElectronics Corporation, Frederick, Maryland) which functioned continuously for 30 days. Average resting pain scores measured on the 0-10 numeric rating scale were a median of 0 during the entire treatment period. Six patients avoided opioid use entirely, while the remaining individual required only 5 mg of oxycodone during the first postoperative day.
https://pubmed.ncbi.nlm.nih.gov/36463434/
(0)
(0)Scroll down for more posts ▼
